These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1876104)

  • 1. Clinical trail of multiple treatment agents for cocaine dependence: a placebo-control; elimination study.
    Tennant F
    NIDA Res Monogr; 1990; 105():512-3. PubMed ID: 1876104
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological and behavioral treatments of cocaine dependence: controlled studies.
    O'Brien CP; Childress AR; Arndt IO; McLellan AT; Woody GE; Maany I
    J Clin Psychiatry; 1988 Feb; 49 Suppl():17-22. PubMed ID: 3276670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.
    Halikas JA; Crosby RD; Pearson VL; Graves NM
    Clin Pharmacol Ther; 1997 Jul; 62(1):89-105. PubMed ID: 9246023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic approaches to the treatment of cocaine dependence.
    Taylor WA; Gold MS
    West J Med; 1990 May; 152(5):573-7. PubMed ID: 1971975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritanserin in the treatment of cocaine dependence.
    Johnson BA; Chen YR; Swann AC; Schmitz J; Lesser J; Ruiz P; Johnson P; Clyde C
    Biol Psychiatry; 1997 Nov; 42(10):932-40. PubMed ID: 9359980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving conceptualizations of cocaine dependence.
    Gawin FH; Kleber HD
    Yale J Biol Med; 1988; 61(2):123-36. PubMed ID: 3043925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of potential treatment medications for cocaine dependence.
    McCance EF
    NIDA Res Monogr; 1997; 175():36-72. PubMed ID: 9467792
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychopharmacologic treatment of cocaine dependence.
    Blaine JD; Ling W
    Psychopharmacol Bull; 1992; 28(1):11-4. PubMed ID: 1609036
    [No Abstract]   [Full Text] [Related]  

  • 10. Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research.
    Kreek MJ
    NIDA Res Monogr; 1997; 175():5-35. PubMed ID: 9467791
    [No Abstract]   [Full Text] [Related]  

  • 11. The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence.
    Cacciola JS; Alterman AI; O'Brien CP; McLellan AT
    NIDA Res Monogr; 1997; 175():182-91. PubMed ID: 9467798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials.
    Carroll KM; Nich C; Rounsaville BJ
    NIDA Res Monogr; 1997; 175():137-57. PubMed ID: 9467796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of marijuana (cannabis) use and dependence in cocaine dependence.
    Miller NS; Klahr AL; Gold MS; Sweeney K; Cocores JA
    N Y State J Med; 1990 Oct; 90(10):491-2. PubMed ID: 2234615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open trial of maprotiline for the treatment of cocaine abuse: a pilot study.
    Brotman AW; Witkie SM; Gelenberg AJ; Falk WE; Wojcik J; Leahy L
    J Clin Psychopharmacol; 1988 Apr; 8(2):125-7. PubMed ID: 3286685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
    Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine treatment of cocaine abuse in heroin addicts.
    Pollack MH; Rosenbaum JF
    J Clin Psychiatry; 1991 Jan; 52(1):31-3. PubMed ID: 1988415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
    Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
    Batki SL; Manfredi LB; Jacob P; Jones RT
    J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and research perspectives on cocaine abuse: the pharmacotherapy of cocaine abuse.
    Kosten TR
    NIDA Res Monogr; 1993; 135():48-56. PubMed ID: 8289903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.